Business Pot firm HYTN receives license to produce and sell psilocybin HYTN can possess up to 300gr of psilocybin and sell it in other countries Natalia Buendia CalvilloOctober 17, 2022
Psychedelics People are taking large doses of psychedelics to treat pain: survey study Although the effects were weaker and more prone to bias, microdoses also seemed to be efficient in pain management Natalia Buendia CalvilloOctober 6, 2022
Research ‘Endogenous’ DMT plays an important role in animal physiology: study review DMT is the backbone structure of popular psychedelics being tested for medical purposes such as psilocin and LSD Natalia Buendia CalvilloOctober 3, 2022
Business Optimi enters psilocybin supply agreement to open healthcare centre in Costa Rica The psilocybin producer will be working with the Knowde Group, Inc., BC Green Pharmaceuticals Inc. and Promises Innovative Recovery (PIR) Natalia Buendia CalvilloAugust 30, 2022
Business Numinus reports sequential revenue dip of 5.7% The drop was due to a shift in Numinus Bioscience operations Natalia Buendia CalvilloJuly 15, 2022
Psychedelics MAPS has immense fundraising success Christie's helps psychedelic research group generate unprecedented revenue via crypto-asset art auction Rowan DunneJuly 4, 2022
Business Numinus completes Novamind acquisition, upgrades leadership team Novamind's clinics in Utah and Arizona will continue to operate as their current brand until later this year Natalia Buendia CalvilloJune 14, 2022
Business Optimi Health enters psilocybin mushroom supply agreement with Halucenex Life Sciences The shrooms will be supplied to Halucenex in the form of whole, dried mushroom fruiting bodies Natalia Buendia CalvilloMay 27, 2022
Business Field Trip to split into two independent companies Current shareholders of the firm will receive shares of each company Natalia Buendia CalvilloMay 3, 2022
Culture Numinus announces Music as Medicine event series Series of concerts across the U.S. and Canada will explore music’s role in psychedelic-assisted therapy Ryan GarnerMay 3, 2022